Accessibility Menu
Cryomass Technologies logo

Cryomass Technologies(OTC) CRYM

Current Price$0.00
Market Cap$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-100%
1 Year-100%
1 Month+0%
Cryomass Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-22
Cryomass Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-07
1 month+0%USD 0.002026-06-18
3 month+0%USD 0.002026-04-22
Year to date+0%USD 0.002025-12-30
1 year-99.99%USD 0.022025-07-21
3 year-100%USD 0.142023-07-21
5 year-100%USD 0.242021-07-23
Since inception-100%USD 0.582014-06-03

Cryomass Technologies Financials at a Glance

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$37.74K

Net Income (TTM)

-$8.82M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

242.82 (High)

Price

$0.00

Volume

70

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Nov 6, 2025

CRYM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cryomass Technologies

Cryomass Technologies Inc. is a specialized company focused on the development and commercialization of cryo-mechanical systems for processing premium botanical materials, including hemp and cannabis. Established in 2011 and based in Denver, Colorado, the company rebranded in 2021 to enhance its market presence.

Products and Services
  • Cryo-mechanical systems for processing botanical materials
  • Innovative solutions tailored for the hemp and cannabis industries
  • Research and development in cryogenic technology applications
Growth Outlook
  • Expansion into the growing cannabis market presents significant opportunities
  • Increasing demand for innovative processing solutions in the botanical sector
  • Strategic partnerships may enhance market reach and product offerings
Financial Highlights
  • Recent quarterly revenue of $5,000, reflecting ongoing operational challenges
  • Trailing twelve months (TTM) revenue of $39,689, indicating potential for growth
  • Net income for Q3 2024 reported at -$1,101,933, highlighting financial pressures
Cryomass Technologies Inc. operates in the Drug Manufacturers - Specialty & Generic industry, focusing on innovative solutions for the processing of botanical materials. The company has faced financial challenges, as evidenced by its recent quarterly results, which show a revenue of $5,000 and a net income loss of over $1 million. Despite these challenges, the company is positioned in a growing market, with increasing demand for its specialized products and services. The potential for strategic partnerships and market expansion could provide avenues for future growth, making Cryomass Technologies Inc. a company to watch in the evolving landscape of the botanical processing industry.
AI Generated • Jul 24, 2026

Industry

Machinery

Sector

Industrials

Employees

11

CEO

Christian Noël

Website

cryomass.com

Headquarters

Denver, CO 80204, US

CRYM Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-79560.21%

Net Income Margin

-95602.13%

Return on Equity

2032.67%

Return on Capital

N/A

Return on Assets

-1332.23%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

237.16M

Volume

70

Avg. Volume

2.91K

Financials (TTM)

Gross Profit

$37.74K

Operating Income

-$4.62M

EBITDA

-$8.08M

Operating Cash Flow

-$1.09M

Capital Expenditure

-$102.54K

Free Cash Flow

-$1.19M

Cash & ST Invst.

$183.44K

Total Debt

$3.32M

Cryomass Technologies Performance Analysis

Cryomass Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 13,552N/A
Cryomass Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31N/A
Q12024-03-31-60.9%
Q22024-06-30162.1%
Q32024-09-30-64.0%
Cryomass Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.06N/A
20222022-12-31USD -0.05-17.0%
20232023-12-31USD -0.0620.6%
Cryomass Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-141.4%
Q12024-03-3126.0%
Q22024-06-3041.6%
Q32024-09-3037.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$5.00K

N/A

Gross Profit

$5.00K

+116.6%

Gross Margin

100.00%

N/A

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$33.33

N/A

Employees

6

N/A

Net Income

-$1.10M

+24.2%

EBITDA

-$924.00K

+29.7%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$183.44K

+1834.0%

Total Debt

$3.32M

+25.0%

Accounts Receivable

$6.19K

N/A

Inventory

$0.00

N/A

Long Term Debt

$594.80K

-75.5%

Short Term Debt

$2.73M

+1087.9%

Return on Assets

-13.32%

N/A

Return on Invested Capital

7.09%

N/A

Free Cash Flow

-$389.46K

+56.7%

Operating Cash Flow

-$285.54K

+67.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RDDTFRadient Technologies Inc.
$0.00+0.00%
KAYSKaya Holdings, Inc.
$0.00+50.00%
TLLTFTILT Holdings Inc.
$0.00-50.00%
KOANResonate Blends, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%
TAT&T
$24.13+0.05%

Questions About CRYM

What is the current price of Cryomass Technologies?

Cryomass Technologies is trading at $0.00 per share.

What is the 52-week range for Cryomass Technologies?

Over the past 52 weeks, Cryomass Technologies has traded between $0.00 and $0.02.

How much debt does Cryomass Technologies have?

As of the most recent reporting period, Cryomass Technologies reported total debt of $3.32M.

How much cash does Cryomass Technologies have on hand?

Cryomass Technologies reported $183.44K in cash and cash equivalents in its most recent financial results.

What is Cryomass Technologies’s dividend yield?

Cryomass Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services